CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

Cited by (571)

Items 401–500 of 571

  1. Development of β-sheet structure in Aβ aggregation intermediates diminishes exposed hydrophobic surface area and enhances proinflammatory activity
    Kapur B. Dhami, Sanjib Karki, Antanisha Parks, Cameron G. Nichols, Michael R. Nichols · 2022 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  2. Using Stems to Bear Fruit: Deciphering the Role of Alzheimer’s Disease Risk Loci in Human-Induced Pluripotent Stem Cell-Derived Microglia
    Edward S. Wickstead · 2023 · Biomedicines
  3. Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
    Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, Keith A. Webster, Lina A. Shehadeh · 2023 · Biomedicines
  4. The regulation of microglia by aging and autophagy in multiple sclerosis
    Xiying Wang, Ye Sun, Haojun Yu, Chunran Xue, Xuzhong Pei, Yi Chen, Yangtai Guan · 2025 · Pharmacological Research
  5. The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer’s Disease
    Marta Matuszewska, Magdalena Cieślik, Anna Wilkaniec, Marcin Strawski, Grzegorz Arkadiusz Czapski · 2022 · International Journal of Molecular Sciences
  6. Molecular and Structural Insight into Adenosine A2A Receptor in Neurodegenerative Disorders: A Significant Target for Efficient Treatment Approach
    Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy · 2023 · Molecular Neurobiology
  7. Amyloid-beta (1-42) lesion of CA1 rat dorsal hippocampus reduces contextual fear memory and increases expression of microglial genes regulating neuroinflammation
    Oluwadamilola Faith Shallie, Musa Vuyisile Mabandla · 2020 · Behavioural Brain Research
  8. Single Cell-type Integrative Network Modeling Identified Novel Microglial-specific Targets for the Phagosome in Alzheimer’s disease
    Kruti Rajan Patel, Kuixi Zhu, Marc Henrion, Noam D. Beckmann, Sara Moein, Melissa L. Alamprese, Mariet Allen, Xue Wang, Gail Chan, Thomas Pertel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Immunohistochemical characterization of CD33 expression on microglia in Nasu‐Hakola disease brains
    Jun‐ichi Satoh, Yoshihiro Kino, Nobutaka Motohashi, Tsuyoshi Ishida, Saburo Yagishita, Kenji Jinnai, Nobutaka Arai, Kiyotaka Nakamagoe, Akira Tamaoka, Yuko Saito et al. · 2015 · Neuropathology
  10. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment
    Edward S. Wickstead, Murray A. Irving, Stephen J. Getting, Simon McArthur · 2021 · FEBS Journal
  11. Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention
    Caterina Scuderi, Lorenzo Golini · 2021 · Animals
  12. Heparan sulfate from porcine mucosa promotes amyloid-beta clearance in APP/PS1 mice and alleviates Alzheimer's pathology
    Lidan Wu, Wenjie Jiang, Na Zhao, Fengshan Wang · 2022 · Carbohydrate Polymers
  13. Do Alzheimer's Disease Risk Gene Products Actually Act in Microglia?
    Hashioka, Sadayuki, Inoue, Ken, Takeshita, Haruo, Inagaki, Masatoshi · 2020 · Frontiers in Aging Neuroscience
  14. Epigenomics of Alzheimer’s Disease
    David Alan Bennett, Lei Yu, Jingyun Yang, Hans‐Ulrich Klein, Philip L. De Jager · 2017 · Elsevier eBooks
  15. Evolution of Human-Specific Alleles Protecting Cognitive Function of Grandmothers
    Sudeshna Saha, Naazneen Khan, Troy J. Comi, Andrea Verhagen, Aniruddha Sasmal, Sandra L. Diaz, Hai Yu, Xi Chen, Joshua M. Akey, Martin Frank et al. · 2022 · Molecular Biology and Evolution
  16. The Genetic Basis of Alzheimer's Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  17. Reduced Smoothened level rescues Aβ-induced memory deficits and neuronal inflammation in animal models of Alzheimer's disease
    Weiwei Ma, Mengnan Wu, Siyan Zhou, Ye Tao, Zuolei Xie, Yi Zhong · 2018 · Journal of genetics and genomics/Journal of Genetics and Genomics
  18. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice
    Kathrin Gnoth, Stefanie Geißler, Julia Silvia Feldhaus, Nadine Taudte, Victoria Ilse, Sebastian Zürner, Sebastian Greiser, Ulf‐Dietrich Braumann, Jens‐Ulrich Rahfeld, Holger Cynis et al. · 2022 · Biomolecules
  19. Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
    Lisa Nicolai, Pauline Nettesheim, Lot D. de Witte, Gijsje J. L. Snijders · 2023 · Journal of Affective Disorders Reports
  20. Recent advances in Alzheimer’s disease pathogenesis and therapeutics from an immune perspective
    Thai-Duong Nguyen, Loi Nguyen Dang, Jung‐Hee Jang, Soyeun Park · 2023 · Journal of Pharmaceutical Investigation
  21. TMF Attenuates Cognitive Impairment and Neuroinflammation by Inhibiting the MAPK/NF-κB Pathway in Alzheimer’s Disease: A Multi-Omics Analysis
    Yonglin Liu, Xi Xu, Xiaoming Wu, Guodong Yang, Jiaxin Luo, Xin‐Li Liang, Jie Chen, Yiguang Li · 2025 · Marine Drugs
  22. Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study
    Zhengshi Yang, Sarah Jane Banks, Aaron R. Ritter, Jeffrey L. Cummings, Karthik Ramakrishnan Sreenivasan, Jefferson W. Kinney, Jessica K. Caldwell, Christina G. Wong, Justin B. Miller, Dietmar Cordes · 2023 · Journal of Alzheimer s Disease
  23. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis
    Li, Bei, Chen, Meiling, Aguzzi, Adriano, Zhu, Caihong · 2021 · Journal of Molecular Medicine
  24. Crosstalk between peripheral immunity and central nervous system in Alzheimer’s disease
    Han-Chen Yang, Qi Qin, Meng Wang, Yunsi Yin, Ruiyang Li, Yi Tang · 2023 · Cellular Immunology
  25. Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
    Clara Duran-Castells, Anna Prats, Bruna Oriol-Tordera, Anuska Llano, Cristina Gálvez, Javier Martínez‐Picado, Ester Ballana, Edurne García-Vidal, Bonaventura Clotet, José A. Muñoz-Moreno et al. · 2023 · EBioMedicine
  26. Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer’s disease: A bibliometric analysis and visualization study from 2002 to 2022
    Fanjing Kong, Tianyu Wu, Jingyi Dai, Jie Cai, Zhenwei Zhai, Zhishan Zhu, Ying Xu, Tao Sun · 2024 · PLoS ONE
  27. CD33 Ameliorates Surgery-Induced Spatial Learning and Memory Impairments Through TREM2
    Jie Zou, Yaxuan Wang, Xinyue Zhang, Xue Pan, Te Fang, Dasheng Cai, Lili Guo, Yu Li, Yi He, Xuezhao Cao · 2024 · Molecular Neurobiology
  28. Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders
    Yajuan Wang, Alzheimer’s Disease Neuroimaging Initiative, Yu Wan, Hui-Fu Wang, Chen‐Chen Tan, Jieqiong Li, Jin‐Tai Yu, Lan Tan · 2019 · Journal of Alzheimer s Disease
  29. The CD33 genotype associated cognitive performance was bidirectionally modulated by intrinsic functional connectivity in the Alzheimer’s disease spectrum
    Liang Gong, Ronghua Xu, Lin Lan, Duan Liu, Jie Shen, Bei Zhang · 2019 · Biomedicine & Pharmacotherapy
  30. Alzheimer’s Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis
    Juraj Javor, Mária Bucová, Vladimı́ra Ďurmanová, Dominika Radošinská, Zuzana Párnická, Daniel Čierný, Egon Kurča, Daniela Čopíková‐Cudráková, Karin Gmitterová, Ivana Shawkatová · 2022 · Life
  31. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late‐onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele
    Juraj Javor, Vladimı́ra Ďurmanová, Zuzana Párnická, Gabriel Minárik, Mária Králová, Ján Pečeňák, Barbora Vašečková, Veronika Režnáková, Stanislav Šutovský, Karin Gmitterová et al. · 2020 · International Journal of Immunogenetics
  32. New Insight in The Molecular Mechanisms of Neurodegenerative Disease
    Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya · 2018 · The Indonesian Biomedical Journal
  33. Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer’s disease
    Akhil Sharma, Thakur Gurjeet Singh · 2025 · Brain Research
  34. CD33 and SHP-1/PTPN6 Interaction in Alzheimer’s Disease
    Lien Beckers, Mamunur Rashid, Annie Lee, Zena K. Chatila, Kirstin A. Tamucci, Ryan Talcoff, Jennifer L. Hall, David Bennett, Badri Narayan Vardarajan, Elizabeth M. Bradshaw · 2024 · Genes
  35. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant
    Daniel Felsky, Philip L. De Jager, Julie A. Schneider, Konstantinos Arfanakis, Debra A. Fleischman, Zoe Arvanitakis, William G. Honer, Jennie G. Pouget, Romina Mizrahi, Bruce G. Pollock et al. · 2016 · Journal of Cerebral Blood Flow & Metabolism
  36. Acquired immunity and Alzheimer's disease
    Weixi Feng, Yanli Zhang, Peng Gang Sun, Ming Xiao · 2022 · Journal of Biomedical Research
  37. The Genetic Basis of Alzheimer’s Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  38. Pseudogene-Mediated Gene Conversion After CRISPR-Cas9 Editing Demonstrated by Partial CD33 Conversion with SIGLEC22P
    Benjamin C. Shaw, Steven Estus · 2021 · The CRISPR Journal
  39. A Common Haplotype Lowers PU.1 Expression in Myeloid Cells and Delays Onset of Alzheimer's Disease
    Huang, Kuan-lin, Marcora, Edoardo, Pimenova, Anna A, Di Narzo, Antonio F, Kapoor, Manav, Jin, Sheng Chih, Harari, Oscar, Bertelsen, Sarah, Fairfax, Benjamin P, Czajkowski, Jake et al. · 2017
  40. The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
    Tenielle Porter, Aleksandra Gozt, Francis L. Mastaglia, Simon Matthew Laws · 2019 · Wiley eBooks
  41. Interplay between CD33 and TREM2 in Alzheimer’s Disease: Potential Mechanistic Insights into Microglial Function in Amyloid Pathology
    Elizabeth Toyin Akinluyi, Kei Takahashi, Meghan G. Connolly, Wayne W. Poon, Matthew Scott Macauley · 2025 · ACS Chemical Neuroscience
  42. Genetic causal relationship between multiple immune cell phenotypes and Parkinson’s disease: a two-sample bidirectional Mendelian randomization study
    Hong Chen, Wang Xie, Ze Chang, Juan Zhang, Daojun Xie · 2024 · Journal of Neurophysiology
  43. Scopoletin Ameliorates Lipopolysaccharide Induced Neuroinflammation, Oxidative Stress and Cognitive Dysfunction in Mice: A Mechanistic Study
    Malvika Gursahani, Nitin Bhanudas Gawali, Sarayu Arvind Pai, Snehal Nitin Mestry, Archana Ramesh Juvekar · 2021 · Journal of Pharmaceutical Research International
  44. Druggable targets for the immunopathy of Alzheimer's disease
    Donald Fredric Weaver · 2023 · RSC Medicinal Chemistry
  45. Association between Alzheimer’s disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan
    Tsung-Jen Hsieh, Alzheimer’s Disease Neuroimaging Initiative, Wei‐Ju Lee, Yi‐Chu Liao, Chih‐Cheng Hsu, Yao‐Hwei Fang, Tzu‐Yu Chen, Yung‐Shuan Lin, I‐Shou Chang, Shuu‐Jiun Wang et al. · 2021 · Aging
  46. Can MRI T1 be used to detect early changes in 5xFAD Alzheimer’s mouse brain?
    Nicholas G. Spencer, David Paul Lovell, Kay Elderfield, Brian Austen, Franklyn A. Howe · 2016 · Magnetic Resonance Materials in Physics Biology and Medicine
  47. Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence
    Tamlyn Watermeyer, Vanessa Raymont, Karen A. Ritchie · 2018 · Journal of Alzheimer’s Disease & Parkinsonism
  48. Human peripheral monocytes capture elements of the state of microglial activation in the brain
    Daniel Felsky, Hans‐Ulrich Klein, Vilas Menon, Yiyi Ma, Yanling Wang, Milos S. Milic, Peter Zhukovsky, Julie A. Schneider, David Alan Bennett, Philip L. De Jager · 2022 · Research Square
  49. Intracerebral inoculation of healthy non-transgenic rats with a single aliquot of oligomeric amyloid-β (1–42) profoundly and progressively alters brain function throughout life
    Marco Krämer, Thu‐Huong Hoang, Honghong Yang, Olena Shchyglo, Juliane Böge, Ute Neubacher, Jens Colitti-Klausnitzer, Denise Manahan‐Vaughan · 2024 · Frontiers in Aging Neuroscience
  50. CD33 polymorphisms and Parkinson’s disease Parkinson’s disease in northern Chinese Han population: A case-control study
    Qing Tian, Xiaohui Sun, Chengqian Li, Yong Yang, Binghui Hou, Anmu Xie · 2023 · Neuroscience Letters
  51. The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer’s disease
    Seoyoung Yoon, Yong‐Ku Kim · 2015 · Global Medical Genetics
  52. Mitochondria at the Base of Neuronal Innate Immunity in Alzheimer’s and Parkinson’s Diseases
    A. Raquel Esteves, Diana Filipa Silva, Daniel Santos, Emanuel Candeias, Filipa Filipe, Sandra M. Cardoso · 2018 · InTech eBooks
  53. Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes
    Dong Won Kim, Kevin J. Tu, Alice Wei, Ashley Lau, Anabel Gonzalez-Gil, Tiaoyu Cao, Kerstin E. Braunstein, Jonathan P. Ling, Juan Carlos Troncoso, Philip C. Wong et al. · 2022 · Research Square
  54. CD33-CD45 Interaction Reveals a Mechanistic Link to Alzheimer’s Disease Susceptibility
    Nicole Vo, Cory D. Rillahan, Zena K. Chatila, Daniel M. Virga, Jennifer L. Hall, Kirstin A. Tamucci, Mamunur Rashid, Sarah M. Connor, Sana Chintamen, Gaelen Guzman et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Characterizing ferrous versus ferric iron in Alzheimer's disease using X-ray fluorescence imaging and XANES spectroscopy
    Dean Q. Tran, Marios Georgiadis, Philip DiGiacomo, Jeffrey Nirschl, Inma Cobos, Jarrett Rosenberg, Nicholas Paul Edwards, Sharon Bone, Samuel M. Webb, Michael Zeineh · 2026 · Journal of Alzheimer s Disease
  56. Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
    Santiago Rodríguez-Carreiro, Maria del Carmen Nogales, David Jiménez-Galán, Sara Carmona-Lorenzo, Alicia Caro-Martín, Elisa Navarro, Noemí Esteras · 2024 · Regenerative medicine reports .
  57. Coupling relationship between glucose and oxygen metabolisms to serve as an imaging biomarker for Alzheimer’s disease
    Ze Xiao Yang, Jinhua Sheng, Qiao Zhang, Jay Tsai Chien Chou, Yu Xin, Luyun Wang · 2025 · Scientific Reports
  58. Alzheimer’s neuroinflammation: A crosstalk between immune checkpoint PD1-PDL1 and ApoE-Heparin interactions?
    Sachin P. Patil, Juliette DiFlumeri, Justin Wellington, Elena Fattakhova, Michael Oravic · 2022 · Medical Hypotheses
  59. Early Diagnosis of Alzheimer's Disease with Blood Test; Tempting but Challenging.
    Fakhrossadat Farvadi, Fatemeh Hashemi, Azadeh Amini, Molood Alsadat Vakilinezhad, Mohammad Javad Raee · 2023 · PubMed Central
  60. Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer’s Disease
    Bin Wu, Mulan Chen, Ling Meng, Qiuyun Tian, Zhifang Dong · 2024 · Journal of Alzheimer s Disease
  61. CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk
    Roger B. Dodd, Masahiro Enomoto, Ye Zhou, Kanayo Satoh, Yalun Zhang, Fusheng Chen, Beatrice Acheson, Deniz Ghaffari, Elizabeth Sayn-Wittgenstein, Jamie J. Manning et al. · 2026 · Nature Communications
  62. Genetik der Alzheimer-Krankheit
    Thomas Bajaj, Alfredo Ramı́rez, Holger Wagner-Thelen · 2018 · Medizinische Genetik
  63. The Radiogenomics of Late-onset Alzheimer Disease
    Luke W. Bonham, Daniel W. Sirkis, Christopher Paul Hess, Leo P. Sugrue, Jennifer S. Yokoyama · 2019 · Topics in Magnetic Resonance Imaging
  64. Lectin Receptors Expressed on Myeloid Cells
    Gordon D. Brown, Paul R. Crocker · 2017 · ASM Press eBooks
  65. Possible Link between Porphyromonas gingivalis and Amyloidosis in the Pathogenesis of Alzheimer’s and Parkinson’s Disease.
    2020
  66. Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
    Ghazaleh Eskandari‐Sedighi, Madeline C. Crichton, Sameera Zia, Erik Gomez, Chris D. St. Laurent, Leonardo M. Cortez, Zain H. Patel, Gaurav Sidhu, Susmita Sarkar, Vivian Aghanya et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Targeting CD33 With Hesperidin: A Natural Strategy for Acute Myeloid Leukemia Treatment
    Amal Majed H. Alenad, Mohd Shahnawaz Khan, Majed Saleh Alokail, Ajamaluddin Malik, Hamza Ahmad Mohammad Odeibat, Aftab Ahmad Khan, Ahmed Abdur Rehman · 2025 · Chemistry & Biodiversity
  68. Development of early biomarkers of Alzheimer's disease: A precision medicine perspective
    Sumit Sarkar, Nikita Das, Kumar Sambamurti · 2022 · Elsevier eBooks
  69. Correlation between Blood Monocytes and CSF Tau in Alzheimer’s Disease: The Effect of Gender and Cognitive Decline
    Carlotta Ginevra Valentina Cimiotti, Paolo Paganetti, Stefania Rossi, Emiliano Soldini, Leonardo Sacco · 2023 · NeuroSci
  70. The lifestyle for brain health index, the cluster of differentiation 33 (CD33) gene, and cognitive function among rural Chinese older adults: A population-based study
    Yixun Ma, Nan Wang, Heng Zhang, Xiaoyan Liang, Wenxin Fa, Keke Liu, Cuicui Liu, Min Zhu, Na Tian, Xunyao Tian et al. · 2024 · Archives of Gerontology and Geriatrics
  71. Inhibitor of bromodomain and extraterminal domain proteins decreases transcription of Cd33 in the brain of mice subjected to systemic inflammation; a promising strategy for neuroprotection
    Grzegorz Arkadiusz Czapski, Marta Matuszewska, Magdalena Cieślik, Joanna Benigna Strosznajder · 2024 · Folia Neuropathologica
  72. Emerging Microglial Therapies and Targets in Clinical Trial
    Ling Yan, Andrea Crotti · 2024 · Advances in neurobiology
  73. Association of immunity-related gene SNPs with Alzheimer’s disease
    Nisrine Bissar‐Tadmouri, Rayan Kassir, Ali Salami, Saïd El Shamieh · 2024 · Experimental Biology and Medicine
  74. Beyond plaques and tangles: The role of immune cell dysfunction in Alzheimer's disease
    Nasif Hussain, Mohd Moin Khan, Ayushi Sharma, Rakesh Kumar Singh, Rizwan Hasan Khan · 2025 · Neurochemistry International
  75. Sialic Acid-Binding Ig-Like Lectins (Siglecs)
    Cheorl‐Ho Kim · 2022 · Springer eBooks
  76. Neuroinflammation in Alzheimer's Disease
    2020 · Case Medical Research
  77. Identifying Suitable Targets for Alzheimer’s Disease and Other Eight Common Neurological Disorders Using the Human Plasma Proteome: A Mendelian Randomization Study
    Tao Wei, Xiaolei Shi, Wei Sun, Weiyi Song, Shaojiong Zhou, Yiwei Zhao, Zhibin Wang, Yi Tang · 2023 · Journal of Alzheimer s Disease Reports
  78. Advance of immune checkpoint inhibitors in CNS disease
    Jianru Sun, Xiangqi Shao, Xue Wang, Fan Liu · 2023 · Human Brain
  79. The development and physiological and pathophysiological functions of resident macrophages and glial cells
    Nelli Blank-Stein, Marina Mayer, Elvira Mass · 2021 · Advances in immunology
  80. A proteogenomic tool uncovers protein markers for human microglial states
    Verena Claudia Haage, Alex R. Bautista, John F. Tuddenham, Victoria S. Marshe, Rebecca Chiu, Yunduo Liu, Tsering Lama, Shane S. Kelly, Neelang Parghi, Junho Park et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  81. From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer’s disease
    Pinar Peyvand, Pantea Allami, Nima Rezaei · 2025 · Reviews in the Neurosciences
  82. Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
    Aman Mangalmurti, Amelia Bonheur, John R. Lukens · 2026 · Journal of Molecular Biology
  83. Inflammation in central nervous system diseases
    Takashi Shichita, Akihiko Yoshimura · 2016 · Clinical and Experimental Neuroimmunology
  84. The Role of Adaptive and Innate Immunity in Alzheimer’s Disease
    Clive Holmes · 2021 · Cambridge University Press eBooks
  85. Neurological Disease
    Jie Wu, Yutong Zou, Yingchun Xu, Mengxiao Xie, Zhaojing Zheng, Juan Geng · 2021 · Springer eBooks
  86. Does SIGLEC8 localize to the subcellular compartment like the Alzheimer's disease protective CD33 splice variant?
    Chirag Dhar · 2023 · Frontiers in Cellular Neuroscience
  87. New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
    Deepa S. Mandlik, Satish K. Mandlik, Heena Bholaram Choudhary · 2023 · Current Drug Therapy
  88. Artificial Intelligence Technologies for Clinical Data PharmacoAnalytics Case Studies on Alzheimer’s Disease
    Guangyi Zhao, Shuyuan Zhao, Xiang‐Qun Xie · 2023 · Springer eBooks
  89. Acupuncture regulating microglial activation in Alzheimer's disease: Research progress in its neuroinflammation mechanism
    Yuting Wei, Ming-li SU, De-Lin Ren, Xin Zhang, Tiantian Zhu, Xingke Yan · 2024 · 世界针灸杂志:英文版
  90. Alzheimer’s Disease: Beyond the Neuron
    Aradhana Verma, Matthew K. Zabel · 2018 · InTech eBooks
  91. Microglia and macrophages in central nervous systems
    I.K. Hyun Cho · 2022 · Elsevier eBooks
  92. Amyloid-beta and tau pathologies are both necessary to induce novel stage-specific microglia subtypes during Alzheimer’s disease progression
    Dong Won Kim, Kevin J. Tu, Alice Wei, Ashley Lau, Anabel Gonzalez-Gil, Tianyu Cao, Kerstin E. Braunstein, Jonathan P. Ling, Juan Carlos Troncoso, Philip C. Wong et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Evolution of Human-specific Alleles Protecting Cognitive Function of Grandmothers
    Sudeshna Saha, Naazneen Khan, Troy J. Comi, Andrea Verhagen, Aniruddha Sasmal, Sandra L. Diaz, Hai Yu, Xi Chen, Joshua M. Akey, Martin Frank et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Microglial expression of the Wnt signalling modulator DKK2 differs between human Alzheimer’s disease brains and mouse neurodegeneration models
    Nozie D. Aghaizu, Sarah Jolly, Satinder K. Samra, Bernadett Kalmár, Katleen Craessaerts, Linda Greensmith, Patricia C. Salinas, Bart De Strooper, Paul John Whiting · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Intercellular adhesion molecule-1 reprograms microglia to improve cognitive functions by inhibiting ERK/STAT3 signalling pathway in a model of Alzheimer’s disease
    Soumita Goswami, Subhas Chandra Biswas · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Multi-omics analysis highlights the link of aging-related cognitive decline with systemic inflammation and alterations of tissue-maintenance
    Stefano Flor, Thomas Dost, Madlen Haase, Rowena Simon, Simone Ederer, A. Samer Kadibalban, Jan Taubenheim, Maja Olecka, Alesia Walker, Johannes Zimmermann et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Alzheimer-Demenz: Praxis und neue Entwicklungen
    Michael Thomas Heneka · 2014 · InFo Neurologie + Psychiatrie
  98. Mikroglia bei Alzheimer-Demenz
    Jens Wiltfang · 2014 · Nervenheilkunde
  99. The 14th International Conference on Alzheimer's Drug Discovery, 9 – 10 September 2013, in Jersey City, New Jersey
    Marcie A. Glicksman · 2014 · Expert Opinion on Drug Discovery
  100. Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
    Sofia Söllvander · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)